[Major drug-induced lung diseases: adverse effects of newly developed molecular targeted drugs].
Ishikawa
Nobuhisa
N
D000970:Antineoplastic Agents / Q000009:adverse effects*; D000077156:Gefitinib; D018390:Gene Targeting; D006801:Humans; D017563:Lung Diseases, Interstitial / Q000139:chemically induced*; D011799:Quinazolines / Q000009:adverse effects*
D000970:Antineoplastic Agents; D011799:Quinazolines; D000077156:Gefitinib